(Q2 Un-audited): EPS was Tk. (0.03) for October-December 2025 as against Tk. 0.14 for October-December 2024; EPS was Tk. (0.11) for July-December 2025 as against Tk. (0.10) for July-December 2024. NOCFPS was Tk. 0.01 for July-December 2025 as against Tk. 0.05 for July-December 2024. NAV per share was Tk. 10.98 as on December 31, 2025 and Tk. 11.09 as on June 30, 2025. Reasons for deviation: EPS for the period was negative with degrowth of Company's revenue during the 2nd Quarter ended on 31 December 2025 against the prior period. EPS have been decreased due to declining sales during the period. NOCFPS decreased due to less recovery of receivables during the period. As a result, NOCFPS decreased in comparison with the previous period. NAV Per share decreased due to negative EPS comparing with the previous year. (end)

The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on August 06, 2026 at 3:00 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended June 30, 2026.

Record Date for entitlement of coupon payment of 05Y BGTB 09/08/2028 Government Securities is 06.08.2026.

Record Date for entitlement of coupon payment of 2Y BGTB 07/08/2026 Government Securities is 06.08.2026. The Government Securities will be delisted effective from 09.08.2026 due to completion of maturity.

The Board of Directors has recommended 10% Cash Dividend for the year ended June 30, 2025. Date of AGM: 03.09.2026, Time & Venue of Hybrid AGM: Will be notified later. Record Date: 06.08.2026. The Company has also reported EPS of Tk. 2.83, NAV per share of Tk. 15.90 and NOCFPS of Tk. 4.48 for the year ended June 30, 2025 as against Tk. 2.61, Tk. 14.07 and Tk. 5.94 respectively for the year ended June 30, 2024. (end)

The Board of Directors has recommended No dividend for the year ended December 31, 2025. Date of AGM: 17.09.2026, Time: 11:00 AM, Venue: Physical presence at Padma Life Tower, (Top Floor) 115, Kazi Nazrul Islam Avenue, Banglamotor, Dhaka -1000. Record Date: 06.08.2026.

The Board of Directors has recommended 10% Cash Dividend for the year ended December 31, 2025. Date of AGM: 06.08.2026, Time: 12:00 PM (noon), Venue/Mode: To be notified through the AGM Notice, Record Date: 08.06.2026. The Company has also reported EPS of Tk. 1.13, NAV per share of Tk. 17.36 and NOCFPS of Tk. 1.26 for the year ended December 31, 2025 as against Tk. 1.12, Tk. 17.24 and Tk. 0.05 respectively for the year ended December 31, 2024.

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 04.08.2026 to 09.08.2026 and trading of the shares will remain suspended on record date i.e., 10.08.2026.

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on August 04, 2026 at 3:30 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended December 31, 2025.

Record Date for entitlement of coupon payment of 02 Year BGTB 05/02/2027 Government Securities is 04.08.2026.

Refer to their earlier news of the company disseminated on 08.07.2026, the company has further informed the key features of the rights issuance which are as follows: Purpose: To strengthen capital base of the Bank in order to comply with the Basel III capital accord, directed by Bangladesh Bank & to support the business growth., Amount of Issue: BDT 7,751,879,490.00, Issue Price: BDT 10 each for each share, Number of Shares to be Issued: 77,51,87,949 units of ordinary shares, Record Date for Determination of Entitlement of Rights Issue: 04 August 2026, Subscription Opening Day: 23 August 2026 and Subscription Closing Day: 20 September 2026 (end)

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 03.08.2026 to 04.08.2026 and trading of the shares will remain suspended on record date i.e., 06.08.2026.

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle from 03.08.2026 to 06.08.2026 and trading of the shares will remain suspended on record date i.e., 09.08.2026.

The Trustee for the UCB 2nd Perpetual Bond, at its meeting on 30 July 2026, informed the semi-annual coupon payment details for the bondholders in the following manner: a) Coupon Payment Period: 7 August 2026 to 6 February 2027 b) Coupon Rate: 10% p.a.

(Q2 Un-audited): Consolidated EPS was Tk. 0.38 for April-June 2026 as against Tk. 0.29 (restated) for April-June 2025; Consolidated EPS was Tk. 0.95 for January-June 2026 as against Tk. 1.09 (restated) for January-June 2025. Consolidated NOCFPS was Tk. (10.43) for January-June 2026 as against Tk. 23.09 (restated) for January-June 2025. Consolidated NAV per share was Tk. 23.46 as on June 30, 2026 and Tk. 22.54 (restated) as on June 30, 2025. Reasons for Deviation: EPS decreased due to decrease in operating income and higher amount of Income Tax provision accounted for during the reporting period (January-June, 2026) in comparison with the previous period of 2025 and NOCFPS decreased due to decrease of deposits in January-June, 2026 half-year in comparison with the previous period of 2025. (end)

(Q2 Un-audited): Consolidated EPS was Tk. (1.85) for April-June 2026 as against Tk. (2.44) for April-June 2025; Consolidated EPS was Tk. (3.65) for January-June 2026 as against Tk. (4.20) for January-June 2025. Consolidated NOCFPS was Tk. (0.21) for January-June 2026 as against Tk. 2.01 for January-June 2025. Consolidated NAV per share was Tk. (99.97) as on June 30, 2026 and Tk. (78.53) as on June 30, 2025.

(Q2 Un-audited): Consolidated EPS was Tk. 0.72 for April-June 2026 as against Tk. 0.78 for April-June 2025; Consolidated EPS was Tk. 0.86 for January-June 2026 as against Tk. 0.83 for January-June 2025. Consolidated NOCFPS was Tk. 7.63 for January-June 2026 as against Tk. 15.89 for January-June 2025. Consolidated NAV per share was Tk. 21.81 as on June 30, 2026 and Tk. 21.16 as on December 31, 2025. Reasons for Deviation: Consolidated EPS in the reporting quarter has been increased due to Investment income increased compare to previous corresponding quarter. Consolidated NOCFPS in the reporting period has been decreased due to low deposit growth compare to same corresponding year. (end)

(Q2 Un-audited): EPS was Tk. 0.10 for April-June 2026 as against Tk. 0.11 for April-June 2025; EPS was Tk. 0.44 for January-June 2026 as against Tk. 0.53 for January-June 2025. NOCFPS was Tk. 0.11 for January-June 2026 as against Tk. 0.12 for January-June 2025. NAV per share was Tk. 22.21 as on June 30, 2026 and Tk. 21.70 as on December 31, 2025

(Q2 Un-audited): As per consolidated life revenue account of the company for the half yearly ended June 30, 2026: Balance of Life Insurance Fund was BDT 42,920.40 million as on June 30, 2026 as against BDT 40,472.78 million as on June 30, 2025. Net premium was BDT 2,597.87 million during April-June 2026 as against BDT 2,451.78 million during April-June 2025. Net premium was BDT 4,866.93 million during January-June 2026 as against BDT 4,391.82 million during January-June 2025. Total expenses were BDT 2,821.13 million during April-June 2026 as against BDT 2,568.03 million during April-June 2025. Total expenses were BDT 5,022.60 million during January-June 2026 as against BDT 4,813.07 million during January-June 2025. (end)

(Q2 Un-audited): Consolidated EPS was Tk. 1.86 for April-June 2026 as against Tk. 1.79 for April-June 2025; Consolidated EPS was Tk. 2.59 for January-June 2026 as against Tk. 2.82 for January-June 2025. Consolidated NOCFPS was Tk. 2.24 for January-June 2026 as against Tk. 5.59 for January-June 2025. Consolidated NAV per share was Tk. 75.83 as on June 30, 2026 and Tk. 70.53 as on December 31, 2025. NOCFPS decreased due to higher net claims in Q2'2026 compared to Q2'2025.